Vasculitis: molecular imaging by targeting the inflammatory enzyme myeloperoxidase.
暂无分享,去创建一个
R. Weissleder | John W. Chen | Y. Iwamoto | E. Aikawa | M. Nahrendorf | P. Panizzi | E. Rodríguez | M. Breckwoldt | H. Su | Ralph Weissleder | Peter R. Panizzi | Elena Aikawa | Henry S Su | John W Chen
[1] K. Nicolay,et al. Tumor Targeting of MMP-2/9 Activatable Cell-Penetrating Imaging Probes Is Caused by Tumor-Independent Activation , 2011, The Journal of Nuclear Medicine.
[2] Min Chen,et al. ANCA-associated vasculitides—advances in pathogenesis and treatment , 2010, Nature Reviews Rheumatology.
[3] Shanrong Zhang,et al. Novel Gd Nanoparticles Enhance Vascular Contrast for High-Resolution Magnetic Resonance Imaging , 2010, PloS one.
[4] R. Weissleder,et al. Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice. , 2010, The Journal of clinical investigation.
[5] R. Weissleder,et al. Activatable magnetic resonance imaging agents for myeloperoxidase sensing: mechanism of activation, stability, and toxicity. , 2010, Journal of the American Chemical Society.
[6] Ralph Weissleder,et al. Enzyme-Sensitive Magnetic Resonance Imaging Targeting Myeloperoxidase Identifies Active Inflammation in Experimental Rabbit Atherosclerotic Plaques , 2009, Circulation.
[7] Emmanuelle Canet-Soulas,et al. Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model. , 2009, Radiology.
[8] M. Langer,et al. Involvement of the ophthalmic artery in giant cell arteritis visualized by 3T MRI. , 2008, Rheumatology.
[9] Ralph Weissleder,et al. Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase , 2008, Proceedings of the National Academy of Sciences.
[10] Patrick A Helm,et al. Postinfarction myocardial scarring in mice: molecular MR imaging with use of a collagen-targeting contrast agent. , 2008, Radiology.
[11] Peter M. Rothwell,et al. Vessel Wall Contrast Enhancement: A Diagnostic Sign of Cerebral Vasculitis , 2008, Cerebrovascular Diseases.
[12] H. Raspe,et al. EULAR recommendations for the management of large vessel vasculitis , 2008, Annals of the rheumatic diseases.
[13] H. Raspe,et al. EULAR recommendations for the management of primary small and medium vessel vasculitis , 2008, Annals of the rheumatic diseases.
[14] R. Weissleder,et al. Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis. , 2008, Brain : a journal of neurology.
[15] P. Libby,et al. Activatable Magnetic Resonance Imaging Agent Reports Myeloperoxidase Activity in Healing Infarcts and Noninvasively Detects the Antiinflammatory Effects of Atorvastatin on Ischemia-Reperfusion Injury , 2008, Circulation.
[16] Ralph Weissleder,et al. Nanoparticle PET-CT Imaging of Macrophages in Inflammatory Atherosclerosis , 2008, Circulation.
[17] M. Walter. [18F]Fluorodeoxyglucose PET in Large Vessel Vasculitis , 2007 .
[18] R. Falk,et al. Nosology of primary vasculitis , 2007, Current opinion in rheumatology.
[19] C. Kallenberg,et al. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides , 2006, Nature Clinical Practice Rheumatology.
[20] Ralph Weissleder,et al. Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. , 2006, Radiology.
[21] J. Hennig,et al. High resolution 3T MRI for the assessment of cervical and superficial cranial arteries in giant cell arteritis , 2006, Journal of magnetic resonance imaging : JMRI.
[22] J. Font,et al. Antineutrophil cytoplasmic antibodies , 2006, The Lancet.
[23] Kazuo Suzuki,et al. Lethal and severe coronary arteritis in DBA/2 mice induced by fungal pathogen, CAWS, Candida albicans water-soluble fraction. , 2006, Atherosclerosis.
[24] Fabien Hyafil,et al. Ferumoxtran-10–Enhanced MRI of the Hypercholesterolemic Rabbit Aorta: Relationship Between Signal Loss and Macrophage Infiltration , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[25] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[26] R. Weissleder,et al. DTPA-bisamide-based MR sensor agents for peroxidase imaging. , 2005, Organic letters.
[27] N. Van Rooijen,et al. Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response1 , 2004, The Journal of Immunology.
[28] T. Oharaseki,et al. Histopathological features of murine systemic vasculitis caused by Candida albicans extract – an animal model of Kawasaki Disease , 2004, Inflammation Research.
[29] E. Topol,et al. Prognostic value of myeloperoxidase in patients with chest pain. , 2003, The New England journal of medicine.
[30] D. Mosser,et al. A novel phenotype for an activated macrophage: the type 2 activated macrophage , 2002, Journal of leukocyte biology.
[31] Kazuo Suzuki,et al. Contribution of Myeloperoxidase to Coronary Artery Vasculitis Associated with MPO-ANCA Production , 2001, Inflammation.
[32] Y. Adachi,et al. Chemical and immunochemical characterization of limulus factor G-activating substance of Candida spp. , 1999, FEMS immunology and medical microbiology.
[33] L. Helm,et al. Structural and Dynamic Parameters Obtained from 17O NMR, EPR, and NMRD Studies of Monomeric and Dimeric Gd3+ Complexes of Interest in Magnetic Resonance Imaging: An Integrated and Theoretically Self-Consistent Approach1 , 1996 .
[34] H. Murata. Experimental Candida‐Induced Arteritis in Mice , 1979, Microbiology and immunology.
[35] M. Nussenzweig,et al. The Journal of Experimental Medicine , 2000 .